These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7270402)

  • 21. Symptoms, haemodynamics, and exercise capacity during long term treatment of chronic heart failure. Experience with pirbuterol.
    Dawson JR; Canepa-Anson R; Kuan P; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Heart J; 1983 Sep; 50(3):282-9. PubMed ID: 6137226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Non-digitalic cardiac inotropic agents].
    Méndez R
    Arch Inst Cardiol Mex; 1981; 51(3):201-5. PubMed ID: 7283531
    [No Abstract]   [Full Text] [Related]  

  • 23. Problems in assessment of new pharmacologic agents for the heart failure patient.
    Rude RE; Grossman W; Colucci WS; Benotti JR; Carabello BA; Wynne J; Malacoff R; Braunwald E
    Am Heart J; 1981 Sep; 102(3 Pt 2):584-90. PubMed ID: 7270403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inodilation--the way ahead in the early therapy of congestive heart failure?
    Opie LH
    Cardiology; 1988; 75 Suppl 1():138-47. PubMed ID: 2853004
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversibility of pulmonary hypertension in congestive heart failure patients evaluated for cardiac transplantation: comparative effects of various pharmacologic agents.
    Murali S; Uretsky BF; Reddy PS; Tokarczyk TR; Betschart AR
    Am Heart J; 1991 Nov; 122(5):1375-81. PubMed ID: 1951003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ibopamine in chronic congestive heart failure: hemodynamic and neurohumoral effects.
    López-Sendón J
    Am J Med; 1991 May; 90(5B):43S-49S. PubMed ID: 1675551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. When should we use nitrates in congestive heart failure?
    Vizzardi E; Bonadei I; Rovetta R; D'Aloia A; Quinzani F; Curnis A; Dei Cas L
    Cardiovasc Ther; 2013 Feb; 31(1):27-31. PubMed ID: 22953723
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New oral drugs for the treatment of congestive heart failure].
    Hayashida W; Kumada T; Kawai C
    Nihon Rinsho; 1992 Feb; 50(2):413-9. PubMed ID: 1319514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Principles of treatment of left ventricular failure.
    Taylor SH; Silke B; Nelson GI
    Eur Heart J; 1982 Dec; 3 Suppl D():19-43. PubMed ID: 6761126
    [No Abstract]   [Full Text] [Related]  

  • 30. A novel inotropic vasodilator, OPC-18790, reduces myocardial oxygen consumption and improves mechanical efficiency with congestive heart failure.
    Kanda H; Yokota M; Ishihara H; Nagata K; Kato R; Sobue T
    Am Heart J; 1996 Aug; 132(2 Pt 1):361-8. PubMed ID: 8701899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.
    Katz SD; Kubo SH; Jessup M; Brozena S; Troha JM; Wahl J; Cohn JN; Sonnenblick EH; LeJemtel TH
    Am Heart J; 1992 Jan; 123(1):95-103. PubMed ID: 1729854
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pharmacotherapy of severe heart failure with inodilators--new approaches].
    Baumann G; Hader O
    Z Kardiol; 1996; 85 Suppl 4():9-19. PubMed ID: 9027110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Principles of the treatment of myocardial failure].
    Korewicki J; Rajecka A; Madeja G
    Kardiol Pol; 1990 Feb; 33(2):126-35. PubMed ID: 2277484
    [No Abstract]   [Full Text] [Related]  

  • 34. Is inotropic therapy appropriate for patients with chronic congestive heart failure? Or is the digitalis leaf withering?
    Uretsky BF
    Postgrad Med J; 1986 Jun; 62(728):585-92. PubMed ID: 2946034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW; Nelson HS
    Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential hemodynamic effects of oral enoximone in severe congestive heart failure.
    Murali S; Uretsky BF; Betschart AR; Tokarczyk TR; Kolesar JA; Reddy PS
    Am J Cardiol; 1990 Feb; 65(7):515-9. PubMed ID: 2137668
    [No Abstract]   [Full Text] [Related]  

  • 37. Oral vasodilator therapy with prazosin in severe congestive heart failure.
    Awan NA; Mason DT
    Am Heart J; 1981 May; 101(5):695-700. PubMed ID: 7223616
    [No Abstract]   [Full Text] [Related]  

  • 38. [Strategies for long-term therapy in advanced, chronic heart insufficiency].
    Bleifeld W
    Internist (Berl); 1984 Jul; 25(7):404-14. PubMed ID: 6381368
    [No Abstract]   [Full Text] [Related]  

  • 39. New concepts and drugs in the treatment of congestive heart failure.
    Friedman WF; George BL
    Pediatr Clin North Am; 1984 Dec; 31(6):1197-227. PubMed ID: 6390312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiotonic agents in the management of chronic cardiac failure.
    Weber KT; Andrews V; Janicki JS
    Am Heart J; 1982 Apr; 103(4 Pt 2):639-49. PubMed ID: 7064806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.